Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/184326
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis |
Autor: | Martínez-Florensa, Mario CSIC; Consuegra-Fernández, Marta; Aranda, Fernando; Armiger-Borràs, Noelia; Di Scala, Marianna; Carrasco, Esther CSIC ORCID; Pachón, Jerónimo CSIC ORCID; Vila, Jordi; González-Aseguinolaza, Gloria; Lozano, Francisco | Palabras clave: | Soluble CD6 Cecal ligation and puncture Polymicrobial peritonitis Scavenger receptors Sepsis Septic shock Adjunctive therapy |
Fecha de publicación: | 2017 | Editor: | American Society for Microbiology | Citación: | Antimicrobial Agents and Chemotherapy 61: 01391-16 (2017) | Resumen: | Sepsis still constitutes an unmet clinical need, which could benefit from novel adjunctive strategies to conventional antibiotic therapy. The soluble form of the scavenger-like human CD6 lymphocyte receptor (shCD6) binds to key pathogenic components from Gram-positive and -negative bacteria and shows time- and dose-dependent efficacy in mouse models of monobacterial sepsis. The objective of the present work was to demonstrate the effectiveness of infusing mouse and human sCD6 by different systemic routes, either alone or as adjunctive therapy to gold standard antibiotics, in a lethal model of polymicrobial sepsis. To this end, C57BL/6 mice undergoing high-grade septic shock induced by cecal ligation and puncture (CLP; ≥90% lethality) were infused via the intraperitoneal (i.p.) or intravenous (i.v.) route with shCD6 at different doses and time points, either alone or in combination with imipenem/cilastatin (I/C) at a dose of 33 mg/kg of body weight every 8 h. Significantly reduced mortality and proinflammatory cytokine levels were observed by i.p. infusion of a single shCD6 dose (1.25 mg/kg) 1 h pre- or post-CLP. When using the i.v. route, mice survival was significantly extended by starting shCD6 infusion at later time points post-CLP (up to 6 h after CLP). Significant adjunctive effects on mouse survival were observed by i.p. or i.v. infusion of shCD6 in combination with i.p. I/C post-CLP. Similar results were obtained in mice expressing high sustained levels (5 to 10 μg/ml) of mouse sCD6 in serum by means of transduction with hepatotropic adeno-associated virus (AAV). Taken together, the data support the conserved antibacterial effects of human and mouse sCD6 and their use as adjunctive therapy in experimental models of complex and severe polymicrobial sepsis. | Versión del editor: | https://doi.org/10.1128/AAC.01391-16 | URI: | http://hdl.handle.net/10261/184326 | DOI: | 10.1128/AAC.01391-16 | ISSN: | 0066-4804 | E-ISSN: | 1098-6596 | Referencias: | Martínez-Florensa, Mario ; Consuegra-Fernández, Marta; Aranda, Fernando; Armiger-Borràs, Noelia; Di Scala, Marianna; Carrasco, Esther ; Pachón, Jerónimo ; Vila, Jordi; González-Aseguinolaza, Gloria; Lozano, Francisco. Erratum for Martínez-Florensa et al., “Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis”. https://doi.org/10.1128/AAC.01997-17 . http://hdl.handle.net/10261/184330 |
Aparece en las colecciones: | (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 59,24 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
6
checked on 10-abr-2024
SCOPUSTM
Citations
11
checked on 16-abr-2024
WEB OF SCIENCETM
Citations
8
checked on 25-feb-2024
Page view(s)
211
checked on 18-abr-2024
Download(s)
24
checked on 18-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.